Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies

Journal of Molecular Diagnostics(2021)10.1016/j.jmoldx.2020.10.013Source: DataRank Database

Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies is a research paper published in Journal of Molecular Diagnostics (2021). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.73)OA: greenTopics (62)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Takeshi Takayasu ORCID,Soheil Zorofchian Moghadamtousi,Octavio Arevalo ORCID,Melissa Chen ORCID,Chieh Lan

Live enrichment

PubMed:33531134 PMC:PMC7874332 OpenAlex:https://openalex.org/W3127812426

National Institutes of Health

Grant: K08CA241651

National Institutes of Health

Grant: 5K08CA241651-02

Development and Validation of a CSF Liquid Biopsy for Molecular Characterization and Monitoring of Patients with Central Nervous System Tumors

National Cancer Institute

FWCI

1.73

Citation Percentile

0.8%

Influential Citations

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier Non-Commercial

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7874332

HYBRIDhttp://www.jmdjournal.org/article/S1525157820305365/pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7874332

publisherhttps://api.elsevier.com/content/article/PII:S1525157820305365?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525157820305365?httpAccept=text/plain

Fields of Study

Cancer Genomics and DiagnosticsLung Cancer Treatments and MutationsGlioma Diagnosis and TreatmentMedicine0301 basic medicine0303 health sciences03 medical and health sciencesAdultAgedBiological AssayCell-Free SystemCentral Nervous System NeoplasmsCirculating Tumor DNADNA Copy Number VariationsFemaleGenome, HumanHumansMaleMiddle AgedMutationYoung Adult

MeSH Terms

Circulating Tumor DNAAdultAgedBiological AssayCell-Free SystemFemaleHumansMaleMiddle AgedMutationGenome, HumanCentral Nervous System NeoplasmsYoung AdultDNA Copy Number Variations

Keywords

Cerebrospinal fluidLiquid biopsyPathologyCancerBiomarkerCytologyConcordanceMedicineCell-free fetal DNAMalignancyCancer researchBiologyInternal medicineAdultMaleCell-Free SystemDNA Copy Number VariationsGenome, HumanMiddle AgedCirculating Tumor DNACentral Nervous System NeoplasmsYoung AdultMutationHumansBiological AssayFemaleAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being